Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling

被引:28
作者
Zhang, Xixia [1 ]
Yang, Jing [1 ]
Bian, Zhigang [1 ]
Shi, Dong [1 ]
Cao, Zhiwei [1 ]
机构
[1] China Med Univ, Dept Otorhinolaryngol, Affiliated ShengJing Hosp, 36 Sanhao Rd, Shenyang 110004, Liaoning, Peoples R China
关键词
Nasopharyngeal carcinoma; Differentiation antagonizing nonprotein coding; RNA; Interleukin-6; Signal transducer and activator of transcription 3; PROSTATE-CANCER; INTERLEUKIN-6; METASTASIS; EXPRESSION; PREDICTS; FEATURES; CELLS;
D O I
10.1016/j.biopha.2019.108713
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Nasopharyngeal carcinoma (NPC) is the most common type of malignancy of the neck and head in Southeast Asia and North Africa. Long noncoding RNA (LncRNA) Differentiation antagonizing nonprotein coding RNA (DANCR) has been reported to exert oncogenic functions in various malignant tumors. However, whether DANCR is involved in NPC tumorgenesis and its underlying mechanisms are still unknown. In the current study, we investigated the expression and biological functions of DANCR in NPC cells and found that DANCR is highly expressed in NPC cells and IL-6 stimulation upregulates DANCR expression through an STAT3-dependent manner. Besides, DANCR knockdown attenuates IL-6-induced proliferation and invasion of NPC cells. Furthermore, DANCR specifically interacts with STAT3 to promote STAT3 activation in NPC cells. Moreover, DANCR knockdown evidently decreases IL-6 induced the association between STAT3 and JAK1 in NPC cells. In addition, we also found that DANCR also indirectly binds to JAK1 through interacting with STAT3 under IL-6 stimulation in NPC cells. Taken together, the present study for the first time demonstrates that DANCR, acting as an oncogene in NPC, promotes NPC progression by interacting with STAT3 and enhancing JAK1 binding to STAT3 to strengthen IL-6/JAK1/STAT3 signaling, suggesting that it may be a potential target to be used as a novel strategy to develop NPC therapeutics.
引用
收藏
页数:8
相关论文
共 32 条
  • [1] NON-CODING RNAs IN DEVELOPMENT AND DISEASE: BACKGROUND, MECHANISMS, AND THERAPEUTIC APPROACHES
    Beermann, Julia
    Piccoli, Maria-Teresa
    Viereck, Janika
    Thum, Thomas
    [J]. PHYSIOLOGICAL REVIEWS, 2016, 96 (04) : 1297 - 1325
  • [2] New developments in the management of nasopharyngeal carcinoma
    Blanchard, P.
    Nguyen, F.
    Moya-Plana, A.
    Pignon, J. P.
    Even, C.
    Bidault, F.
    Temam, S.
    Ruffier, A.
    Tao, Y.
    [J]. CANCER RADIOTHERAPIE, 2018, 22 (6-7): : 492 - 495
  • [3] Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells
    Byun, Hyo Joo
    Darvin, Pramod
    Kang, Dong Young
    Nipin, S. P.
    Joung, Youn Hee
    Park, Jong Hwan
    Kim, Sun Jin
    Yang, Young Mok
    [J]. ONCOLOGY REPORTS, 2017, 37 (06) : 3270 - 3278
  • [4] STAT3 in Prostate Cancer: Whom Should We Treat and When?
    Culig, Zoran
    [J]. EUROPEAN UROLOGY, 2017, 71 (03) : 317 - 318
  • [5] Dianatpour Ali, 2017, Asian Pac J Cancer Prev, V18, P2601
  • [6] Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1
    Ding, Hongda
    Liu, Junpeng
    Liu, Baiming
    Zeng, Yongchao
    Chen, Pengrui
    Su, Yang
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (04) : 973 - 980
  • [7] Expression of STAT3 in Prostate Cancer Metastases
    Don-Doncow, Nicholas
    Marginean, Felicia
    Coleman, Ilsa
    Nelson, Peter S.
    Ehrnstrom, Roy
    Krzyzanowska, Agnieszka
    Morrissey, Colm
    Hellsten, Rebecka
    Bjartell, Anders
    [J]. EUROPEAN UROLOGY, 2017, 71 (03) : 313 - 316
  • [8] Size effect in ion transport through angstrom-scale slits
    Esfandiar, A.
    Radha, B.
    Wang, F. C.
    Yang, Q.
    Hu, S.
    Garaj, S.
    Nair, R. R.
    Geim, A. K.
    Gopinadhan, K.
    [J]. SCIENCE, 2017, 358 (6362) : 511 - 513
  • [9] Identification of Biomarkers for Predicting Nasopharyngeal Carcinoma Response to Radiotherapy by Proteomics
    Feng, Xue-Ping
    Yi, Hong
    Li, Mao-Yu
    Li, Xin-Hui
    Yi, Bin
    Zhang, Peng-Fei
    Li, Cui
    Peng, Fang
    Tang, Can-E
    Li, Jian-Ling
    Chen, Zhu-Chu
    Xiao, Zhi-Qiang
    [J]. CANCER RESEARCH, 2010, 70 (09) : 3450 - 3462
  • [10] Handle F., 2018, MOL CANC THER